Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024

Rhea-AI Summary

Aurinia Pharmaceuticals (NASDAQ: AUPH) has announced it will release its second quarter 2024 financial and operational results on Thursday, August 1, 2024, before markets open. The company's management team will host a conference call and webcast at 8:30 am ET on the same day to review the results and provide a general business update. Interested participants can join via phone or audio webcast, with a replay available on Aurinia's website afterwards.

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the second quarter of 2024 on Thursday, August 1, 2024, before markets open. Aurinia’s management team will host a conference call/webcast at 8:30 am ET that day to review these results and provide a general business update.

Interested participants can dial (866) 682-6100 or (862) 298-0702 (toll-free U.S. & Canada). The audio webcast can also be accessed here. A replay of the webcast will be available on Aurinia’s website.

About Aurinia

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS^® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. The Company’s head office is in Edmonton, Alberta, its U.S. commercial office is in Rockville, Maryland. The Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240719692619/en/

Media and Investor Inquiries:

Andrea Christopher

Corporate Communications and Investor Relations, Aurinia

achristopher@auriniapharma.com

ir@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

When will Aurinia Pharmaceuticals (AUPH) release its Q2 2024 financial results?

Aurinia Pharmaceuticals (AUPH) will release its second quarter 2024 financial and operational results on Thursday, August 1, 2024, before markets open.

What time is Aurinia Pharmaceuticals' (AUPH) Q2 2024 earnings call scheduled for?

Aurinia Pharmaceuticals' (AUPH) Q2 2024 earnings call is scheduled for 8:30 am ET on Thursday, August 1, 2024.

How can investors access Aurinia Pharmaceuticals' (AUPH) Q2 2024 earnings call?

Investors can access Aurinia Pharmaceuticals' (AUPH) Q2 2024 earnings call by dialing (866) 682-6100 or (862) 298-0702 (toll-free U.S. & Canada) or via audio webcast available on the company's website.

Will a replay of Aurinia Pharmaceuticals' (AUPH) Q2 2024 earnings call be available?

Yes, a replay of Aurinia Pharmaceuticals' (AUPH) Q2 2024 earnings call will be available on the company's website after the live event.